Conducting R&D during disease outbreaks can be a drag. Global pharmaceutical companies will struggle to deliver new vaccines, drugs, and diagnostics against global health biothreats unless they leverage lessons learned and key success factors during previous studies to guide clinical research development plans during subsequent outbreaks.   

In this video, I will explain how lessons learned during the 2014-15 West Africa Ebola virus outbreak can supercharge R&D during future outbreaks and help deliver life-saving clinical products to patients and families faster.   

***

Hi, I'm Dr. Amos Ndhere! I am a medical doctor, Clinical Investigator, and Regulatory Affairs Specialist.   

My goal is simple: Help YOU with the right tools, tips, and framework to deliver life-changing treatments to patients faster through clinical research and emerging market access.

***

PS - Join the conversation on social!

 https://www.linkedin.com/in/amosndhere 

https://twitter.com/amosndhere 

https://facebook.com/amosndhere